THEMIS MEDICARE
|
THEMIS MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.24 | 4.73 | 61.83 | 79.22 | 38.86 |
| CEPS(Rs) | 4.32 | 6.06 | 7.32 | 8.95 | 4.82 |
| DPS(Rs) | 0.50 | 0.50 | 5.00 | 5.00 | 4.30 |
| Book NAV/Share(Rs) | 43.74 | 41.03 | 368.78 | 312.22 | 237.41 |
| Tax Rate(%) | 24.81 | 18.56 | 21.53 | 23.49 | 13.62 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.10 | 13.49 | 19.04 | 24.24 | 21.46 |
| EBIT Margin(%) | 12.26 | 16.46 | 23.17 | 26.36 | 23.43 |
| Pre Tax Margin(%) | 9.78 | 14.00 | 20.47 | 24.14 | 17.92 |
| PAT Margin (%) | 7.36 | 11.40 | 16.06 | 18.47 | 15.48 |
| Cash Profit Margin (%) | 9.81 | 14.61 | 19.02 | 20.87 | 19.18 |
| Performance Ratios | |||||
| ROA(%) | 5.08 | 7.91 | 11.78 | 17.93 | 9.97 |
| ROE(%) | 7.65 | 12.14 | 18.16 | 28.84 | 17.82 |
| ROCE(%) | 10.37 | 13.89 | 20.59 | 31.07 | 18.44 |
| Asset Turnover(x) | 0.69 | 0.69 | 0.73 | 0.97 | 0.64 |
| Sales/Fixed Asset(x) | 1.65 | 1.66 | 1.71 | 2.16 | 1.44 |
| Working Capital/Sales(x) | 2.74 | 2.72 | 2.83 | 3.77 | 4.04 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.61 | 0.60 | 0.58 | 0.46 | 0.69 |
| Receivable days | 159.79 | 154.39 | 126.49 | 82.40 | 142.49 |
| Inventory Days | 69.71 | 66.70 | 66.84 | 55.18 | 89.48 |
| Payable days | 166.51 | 138.08 | 130.58 | 87.30 | 163.89 |
| Valuation Parameters | |||||
| PER(x) | 45.24 | 46.31 | 1.89 | 1.18 | 0.72 |
| PCE(x) | 33.95 | 36.14 | 15.93 | 10.42 | 5.82 |
| Price/Book(x) | 3.35 | 5.34 | 3.16 | 2.99 | 1.18 |
| Yield(%) | 0.34 | 0.23 | 0.43 | 0.54 | 1.53 |
| EV/Net Sales(x) | 3.50 | 5.48 | 3.24 | 2.31 | 1.38 |
| EV/Core EBITDA(x) | 26.43 | 37.19 | 14.52 | 8.91 | 5.99 |
| EV/EBIT(x) | 28.56 | 33.30 | 13.97 | 8.75 | 5.89 |
| EV/CE(x) | 2.92 | 4.42 | 2.66 | 2.49 | 1.05 |
| M Cap / Sales | 3.33 | 5.28 | 3.03 | 2.18 | 1.12 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.22 | 7.74 | -10.21 | 71.07 | 14.43 |
| Core EBITDA Growth(%) | -4.52 | -28.74 | -22.73 | 92.37 | 35.77 |
| EBIT Growth(%) | -20.86 | -23.46 | -21.11 | 92.51 | 35.94 |
| PAT Growth(%) | -31.46 | -23.51 | -21.93 | 104.13 | 44.07 |
| EPS Growth(%) | -31.46 | -92.35 | -21.95 | 103.87 | 44.06 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.21 | 0.25 | 0.27 | 0.27 | 0.39 |
| Current Ratio(x) | 1.89 | 1.86 | 1.84 | 1.85 | 1.45 |
| Quick Ratio(x) | 1.38 | 1.43 | 1.38 | 1.35 | 0.99 |
| Interest Cover(x) | 4.95 | 6.70 | 8.58 | 11.86 | 4.25 |
| Total Debt/Mcap(x) | 0.06 | 0.05 | 0.09 | 0.09 | 0.33 |
Compare Financial Ratios of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹928.7 Cr | -2.9% | -14.2% | -60.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,838.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
| CIPLA | ₹129,330.0 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,211.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -2.9% |
-14.2% |
-60.7% |
| SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses
